SEC Form 4 · accession 0001093557-17-000060
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Michael Murphy
Officer — VP, Legal Aff & Chf Compl Ofcr
Period of report
Mar 8, 2017
Accepted (ET)
Mar 10, 2017 · 8:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 8, 2017 | A | 11,361 | $0.001 | A | 40,489 | D | |
| Common StockF3,F2 | Mar 10, 2017 | D | 2,216 | $77.5506 | D | 38,273 | D | |
| Common StockF3,F2 | Mar 10, 2017 | D | 1,611 | $77.5506 | D | 36,662 | D | |
| Common StockF3,F2 | Mar 10, 2017 | D | 2,209 | $77.5506 | D | 34,453 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/3 shall vest 12 months from the Grant Date, and the remaining balance shall vest in four equal installments over the following 24 months. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
- F2Included in this number are 25,592 unvested restricted stock units, 11,361 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 10,000 of which were granted on March 8, 2016 shall vest through March 8, 2019 and 4,231 of which were granted on March 8, 2015 and shall vest through March 8, 2018.
- F3These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.